302 related articles for article (PubMed ID: 36143270)
1. iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine.
Pandey S; Jirásko M; Lochman J; Chvátal A; Chottova Dvorakova M; Kučera R
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143270
[TBL] [Abstract][Full Text] [Related]
2. Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma.
Bahmad H; Hadadeh O; Chamaa F; Cheaito K; Darwish B; Makkawi AK; Abou-Kheir W
Front Mol Neurosci; 2017; 10():50. PubMed ID: 28293168
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases.
Chang EA; Jin SW; Nam MH; Kim SD
J Korean Neurosurg Soc; 2019 Sep; 62(5):493-501. PubMed ID: 31392877
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
[TBL] [Abstract][Full Text] [Related]
6. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.
Jung YW; Hysolli E; Kim KY; Tanaka Y; Park IH
Curr Opin Neurol; 2012 Apr; 25(2):125-30. PubMed ID: 22357218
[TBL] [Abstract][Full Text] [Related]
7. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
[TBL] [Abstract][Full Text] [Related]
8. Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting.
Teli P; Kale V; Vaidya A
Cell Tissue Res; 2023 Oct; 394(1):75-91. PubMed ID: 37572163
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders.
Fanizza F; Campanile M; Forloni G; Giordano C; Albani D
J Tissue Eng; 2022; 13():20417314221095339. PubMed ID: 35570845
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
11. Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.
Devineni A; Tohme S; Kody MT; Cowley RA; Harris BT
Am J Stem Cells; 2016; 5(3):99-106. PubMed ID: 27853631
[TBL] [Abstract][Full Text] [Related]
12. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
Cao L; Tan L; Jiang T; Zhu XC; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
[TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy for Parkinson's disease: safety and modeling.
Stoddard-Bennett T; Pera RR
Neural Regen Res; 2020 Jan; 15(1):36-40. PubMed ID: 31535640
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
[TBL] [Abstract][Full Text] [Related]
15. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
Albert K; Niskanen J; Kälvälä S; Lehtonen Š
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
[TBL] [Abstract][Full Text] [Related]
16. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
[TBL] [Abstract][Full Text] [Related]
17. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
Fan Y; Winanto ; Ng SY
Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
[TBL] [Abstract][Full Text] [Related]
18. iPSCs, aging and age-related diseases.
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
[TBL] [Abstract][Full Text] [Related]
19. Reprint of "iPSCs, aging and age-related diseases".
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2015 Jan; 32(1):169-79. PubMed ID: 25479728
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cells for Treatment of Alzheimer's and Parkinson's Diseases.
Yefroyev DA; Jin S
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
